SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
Loading...
Loading...
Score 8.8 from GitHub Security Advisory (severity: HIGH) published 2022-04-21. NVD baseline CVSS 8.8; sources differ by 0.0.
SAS Drug Development (SDD) before 32DRG02 mishandles logout actions, which allows a user (who was previously logged in) to access resources by pressing a back or forward button in a web browser.
July 31, 2019
November 21, 2024
MITRE Common Weakness Enumeration — the root-cause categories this CVE belongs to.
Every time one of our enrichment pipelines (NVD, MITRE cvelistV5, EPSS, CISA KEV, GHSA, OSV, vendor advisories) ran against this CVE. Most recent first.
See which npm, PyPI, Go, and Maven packages are affected by CVE-2007-6763
EchelonGraph automatically scans your cloud infrastructure and maps CVE exposure using blast radius analysis.